Reconciling the risk of QT interval prolongation in antidepressants
Pharmacoepidemiol Drug Saf
.
2012 Mar;21(3):329-30; author reply 331-2.
doi: 10.1002/pds.3216.
Authors
A J McKean
,
C L Sola
,
C Galardy
,
S Kung
,
T W Lineberry
PMID:
22407598
DOI:
10.1002/pds.3216
No abstract available
Publication types
Letter
Comment
MeSH terms
Antidepressive Agents / adverse effects*
Arrhythmias, Cardiac / chemically induced*
Death, Sudden, Cardiac / etiology*
Female
Humans
Male
Substances
Antidepressive Agents